Form D — Mangrove Therapeutics Inc.
0002111089-26-000001 · filed Jul 31, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $5,000,000
- Reported amount sold
- $2,455,000
- Minimum investment
- $25,000
- Investors
- 9
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Mangrove Therapeutics Inc.
- CIK
- 2111089
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 2108 N ST
SACRAMENTO, CA 95816 - Phone
- (650) 485-3618
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jin Li · DirectorSacramento, CA Find on LinkedIn ↗
-
Benjamin Zhiyi Chen · Executive OfficerSacramento, CA Find on LinkedIn ↗
-
Alexander Simon Green · Executive OfficerSacramento, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗